MBL2 and COVID-19: demonstrated the ability of the SARS-CoV-2 N protein to bind to MASP-2, thereby leading to MBL-dependent activation of the lectin pathway not only in vitro, but also in vivo in COVID-19 patients as well as in a mouse model (23).